GE Healthcare Announces Commercial Availability of New Methodology That Provides a Cancer Profile on a Single SlideMay 31, 2013 9:00 am | by Business Wire | Comments
GE Healthcare today announced at the 2013 Annual Meeting of the American Society of Clinical Oncology its plans for the commercialization of MultiOmyx ™, a ground-breaking new pathology platform, using proprietary methodology to analyze multiple proteins at a single-cell level.
NuVasive, Inc., a medical device company focused on developing minimally disruptive surgical products and procedures for the spine, is excited to announce the global launch of its Maximum Access Surgery Posterior Lumbar Interbody Fusion (MAS® PLIF) procedure.
New Method to Test Breast Lesions Could Better Detect Cancer, Save Money by Reducing Repeat BiopsiesMay 31, 2013 12:05 am | by AACR | Comments
A newly developed, single-step Raman spectroscopy algorithm has the potential to simultaneously detect microcalcifications and enable diagnosis of the associated breast lesions with high precision, according to data published in Cancer Research, a journal of the American Association for Cancer Research.
Research at Lund University in Sweden gives hope that one of the most serious types of brain tumor, glioblastoma multiforme, could be fought by the patients' own immune system. The tumors are difficult to remove with surgery because the tumor cells grow into the surrounding healthy brain tissue. A patient with the disease therefore does not usually survive much longer than a year after the discovery of the tumor.
Stent angioplasty saves lives, but there often are side effects and complications related to the procedure, such as arterial restenosis and thrombosis. In the June 2013 issue of The FASEB Journal, however, scientists report that they have discovered a new nanoparticle gene delivery method that may overcome current limitations of gene therapy vectors and prevent complications associated with the stenting procedure.
Procedures like angioplasty, stenting and bypass surgery may save lives, but they also cause excessive inflammation and scarring, which ultimately can lead to permanent disability and even death. A new research report appearing in The FASEB Journal, shows that naturally derived compounds from polyunsaturated fatty acids (omega-3s) may reduce the inflammation associated with these procedures to help arteries more fully and completely heal.
A new study from Columbia University School of Nursing supports a growing body of evidence that women are less likely to contract bloodstream or surgical site infections than their male counterparts. Researchers investigated the incidence of infection in thousands of hospitalized patients and found the odds for women succumbing to a bloodstream infection (BSI) and surgical-site infection (SSI) were significantly lower than for men.
Two Johns Hopkins gynecologic surgeons are among the first in the nation to perform a robotic hysterectomy using a single, small incision. Amanda Nickles Fader, M.D. and Stacey Scheib, M.D. recently performed several other types of single-site robotic gynecologic procedures—including surgery for fibroids, abnormal uterine bleeding, and ovarian cysts and masses.
A study led by Boston University School of Medicine has identified a novel approach to create an unlimited number of human red blood cells and platelets in vitro. In collaboration with Boston University School of Public Health (BUSPH) and Boston Medical Center (BMC), the researchers differentiated induced pluripotent stem (iPS) cells into these cell types, which are typically obtained through blood donations.
Structural biologists from Rice University and Baylor College of Medicine (BCM) have captured the first three-dimensional crystalline snapshot of a critical but fleeting process that takes place thousands of times per second in each human cell. The research appears online today in the journal Cell Reports and could prove useful in the study of cancer and other diseases.
NJIT Distinguished Professor and electrical engineer Atam Dhawan hits the lecture trail again this summer as a distinguished speaker for an IEEE life sciences lecture series. His focus will be how "Point of Care Healthcare" can reduce illness, improve the quality of life, and stop spiraling healthcare costs. Dhawan, who will stop at conferences in Japan, Colombia and Croatia, tells audiences about the following.
Biozoom Reveals Breakthrough Consumer Product For Massive Fitness, Health And Wellness Markets: Handheld, Real Time Biofeedback ScannerMay 30, 2013 3:31 pm | by PR Newswire | Comments
According to the respected management consulting firm, McKinsey, the global health and wellness market will reach $1 trillion before the decade is out, and Biozoom (BIZM) is poised to be a major force in that growth. Biozoom recently unveiled the world's first mobile, hand held biofeedback health scanner, positioning the company to enter this enormous market across a number of segments.
Human scabs have become the model for development of an advanced wound dressing material that shows promise for speeding the healing process, scientists are reporting. Their study appears in the journal ACS Applied Materials & Interfaces.
Over the past three decades, researchers have found various applications of a method for attaching molecules to gold; the approach uses chemicals called thiols to bind the materials together. But while this technique has led to useful devices for electronics, sensing and nanotechnology, it has limitations. Now, an MIT team has found a new material that could overcome many of these limitations.
Medtronic, Inc. (NYSE: MDT) is expanding its market-leading portfolio of products for endovascular aortic repair in the United States with two new medical devices: the company recently received approval from the U.S. Food and Drug Administration (FDA) for the Endurant II Aorto-Uni-Iliac (AUI) Stent Graft System and the FDA’s 510(k) clearance for the Sentrant Introducer Sheath.